|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 36.24 ZAR | -0.14% |
|
+1.71% | +3.54% |
| Capitalization | 31.06B 1.89B 1.62B 1.51B 1.41B 2.63B 171B 2.83B 17.41B 6.84B 81.56B 7.09B 6.94B 301B | P/E ratio 2026 * |
25.1x | P/E ratio 2027 * | 21x |
|---|---|---|---|---|---|
| Enterprise value | 33.22B 2.02B 1.74B 1.62B 1.51B 2.81B 183B 3.03B 18.62B 7.32B 87.24B 7.58B 7.42B 322B | EV / Sales 2026 * |
0.77x | EV / Sales 2027 * | 0.7x |
| Free-Float |
42.71% | Yield 2026 * |
1.6% | Yield 2027 * | 1.89% |
Last Transcript: Dis-Chem Pharmacies Limited
| 1 day | -0.14% | ||
| 1 week | +1.71% | ||
| Current month | +3.54% | ||
| 1 month | +3.54% | ||
| 3 months | +7.63% | ||
| 6 months | +12.72% | ||
| Current year | +3.54% |
| 1 week | 35.35 |  | 36.68 |
| 1 month | 34.17 | | 36.68 |
| Current year | 34.7 | | 36.68 |
| 1 year | 26.5 | | 37 |
| 3 years | 21.54 | | 40 |
| 5 years | 21 | | 40 |
| 10 years | 16.5 | | 40 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rui Morais
CEO | Chief Executive Officer | 42 | 30/06/2023 |
Julia Pope
DFI | Director of Finance/CFO | 45 | 31/12/2016 |
| Investor Relations Contact | - | 28/02/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Ivan Saltzman
BRD | Director/Board Member | 76 | 31/10/2016 |
Rui Morais
BRD | Director/Board Member | 42 | 31/10/2016 |
Laurence Nestadt
CHM | Chairman | 76 | 31/10/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +4.72% | 0% | 51 M€ | |
| +3.15% | 0% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.14% | +1.71% | +0.64% | +18.59% | 1.9B | |
| +0.45% | +9.92% | +138.03% | +0.30% | 27.6B | |
| +4.59% | +22.16% | +102.99% | -7.76% | 13.19B | |
| +0.13% | -0.87% | +20.30% | +26.06% | 6.68B | |
| -0.25% | +2.74% | -6.15% | +23.01% | 4.98B | |
| +1.91% | +1.36% | -7.36% | -38.97% | 3.83B | |
| -0.21% | +1.57% | -20.95% | -47.33% | 3.26B | |
| -0.05% | +2.72% | +33.50% | -48.52% | 3.03B | |
| +1.16% | -2.53% | -8.44% | +64.42% | 2.83B | |
| -0.79% | -0.06% | +48.64% | - | 2B | |
| Average | +0.57% | +4.13% | +30.12% | -1.13% | 6.93B | |
| Weighted average by Cap. | +0.92% | +10.03% | +77.25% | -0.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 42.92B 2.61B 2.24B 2.09B 1.94B 3.63B 236B 3.91B 24.06B 9.45B 113B 9.79B 9.59B 416B | 47.43B 2.89B 2.48B 2.31B 2.15B 4.01B 261B 4.32B 26.59B 10.45B 125B 10.82B 10.6B 459B |
| Net income | 1.23B 75.03M 64.47M 60.12M 55.86M 104M 6.78B 112M 691M 272M 3.24B 281M 276M 11.94B | 1.45B 88.4M 75.96M 70.83M 65.82M 123M 7.98B 132M 814M 320M 3.82B 332M 325M 14.07B |
| Net Debt | 2.16B 132M 113M 105M 97.94M 183M 11.88B 197M 1.21B 476M 5.68B 493M 483M 20.94B | 2.16B 131M 113M 105M 97.85M 183M 11.87B 197M 1.21B 476M 5.67B 493M 483M 20.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/01/26 | 36.24 R | -0.14% | 546,747 |
| 12/01/26 | 36.29 R | +0.78% | 716,913 |
| 09/01/26 | 36.01 R | +0.73% | 6,688,576 |
| 08/01/26 | 35.75 R | +0.03% | 450,584 |
| 07/01/26 | 35.74 R | +0.31% | 355,384 |
End-of-day quote Johannesburg S.E., January 12, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- DCP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition